Analysis of different therapeutic schemes combining cyclophosphamide and doublestranded DNA preparation for eradication of Krebs-2 primary ascites in mice

In the present paper, we report on the series of experiments where multiple regimens of CP and dsDNA injections were tested for targeting the ascites form of murine Krebs-2 cancer in situ. We show that combining CP with cross-linked human and salmon dsDNA results in a synergistic toxicity for ascites-bearing mice, an observation supported by the histopathology analysis of organs and tissues of experimental animals. In contrast, using a composite mixture of native and cross-linked human and salmon DNA after CP injections leads to a significant increase in average lifespan of the treated mice. Further, we demonstrate that repeated rounds of CP+dsDNA injections result in dramatic anticancer effect. The timing of injections is chosen so that they target the cells that were insensitive to the previous treatments as they were in the G2/M phase. 3-4 rounds of injections are needed to eliminate the subpopulation of tumor-initiating cancer stem cells. Our experiments identified the regimen when complete resorption of the primary Krebs-2 ascites occurs in all of the treated animals, followed by a remarkable remission period lasting 7-9 days. Yet, this regimen does not prevent secondary site metastases (either solid or ascites form) from developing, which is likely caused by the migration of ascites cells into adjacent tissues or by incomplete eradication of cancer stem cells. To address these and other questions, we expanded the study and performed histopathology analysis, which indicated that secondary metastases is not the only cause of death. In fact, many animals displayed unfolding systemic inflammatory reaction which was culminated by multiple organ failure. Thus, we developed the concept for treating ascites form of Krebs-2 cancer, which allows elimination of the primary ascites.

double-stranded DNA, cyclophosphamide (CP), Krebs-2 ascites, tumor-initiating stem cells, remission, NER, homologous recombination, systemic inflammatory reaction, multiple organ failure

1. Alyamkina E.A., Dolgova E.V., Likhacheva A.S., Rogachev V.A., Sebeleva T.E., Nikolin V.P., Popova N.A., Kiseleva E.V., Orishchenko K.E., Sakhno L.V., Gel’fgat E.L., Ostanin A.A., Chernykh E.R., Zagrebelniy S.N., Bogachev S.S., Shurdov M.A. Exogenous allogenic fragmented double-stranded DNA is internalized into human dendritic cells and enhances their allostimulatory activity. Cell Immunol. 2010a; 262:120-126. DOI 10.1016/j.cellimm.2010.01.005

2. Alyamkina E.A., Dolgova E.V., Likhacheva A.S., Rogachev V.A., Sebeleva T.E., Nikolin V.P., Popova N.A., Orishchenko K.E., Strunkin D.N., Chernykh E.R., Zagrebelniy S.N., Bogachev S.S., Shurdov M.A. Combined therapy with cyclophosphamide and DNA preparation inhibits the tumor growth in mice. Genet. Vaccines Ther. 2009;7(1):12. DOI 10.1186/1479-0556-7-12

3. Alyamkina E.A., Leplina O.Y., Ostanin A.A., Chernykh E.R., Nikolin V.P., Popova N.A., Proskurina A.S., Gvozdeva T.S., Dolgova E.V., Orishchenko K.E., Rogachev V.A., Sidorov S.V., Varaksin N.A., Ryabicheva T.G., Bogachev S.S., Shurdov M.A. Effects of human exogenous DNA on production of perforin-containing CD8+ cytotoxic lymphocytes in laboratory setting and clinical practice. Cell Immunol. 2012;276:59-66. DOI 10.1016/j.cellimm.2012.04.004.

4. Alyamkina E.A., Leplina O.Y., Sakhno L.V., Chernykh E.R., Ostanin A.A., Efremov Y.R., Shilov A.G., Proskurina A.S., Orishchenko K.E., Dolgova E.V., Rogachev V.A., Nikolin V.P., Popova N.A., Zagrebelniy S.N., Bogachev S.S., Shurdov M.A. Effect of doublestranded DNA on maturation of dendritic cells in vitro. Cell Immunol. 2010b;266:46-51. DOI 10.1016/j.cellimm.2010.08.011

5. Alyamkina E.A., Nikolin V.P., Popova N.A., Dolgova E.V., Proskurina A.S., Orishchenko K.E., Efremov Y.R., Chernykh E.R., Ostanin A.A., Sidorov S.V., Ponomarenko D.M., Zagrebelniy S.N., Bogachev S.S., Shurdov M.A. A strategy of tumor treatment in mice with doxorubicin-cyclophosphamide combination based on dendritic cell activation by human double-stranded DNA preparation. Genet. Vaccines Ther. 2010c;8(1)(7). DOI 10.1186/1479-0556-8-7.

6. Alyamkina E.A., Nikolin V.P., Popova N.A., Minkevich A.M., Kozel A.V., Dolgova E.V., Efremov Y.R., Bayborodin S.I., Andrushkevich O.M., Taranov O.S., Omigov V.V., Rogachev V.A., Proskurina A.S., Vereschagin E.I., Kiseleva E.V., Zhukova M.V., Ostanin A.A., Chernykh E.R., Bogachev S.S., Shurdov M.A. Combination of cyclophosphamide and double-stranded DNA demonstrates synergistic toxicity against established xenografts. Cancer Cell Int. 2015;15(32). DOI 10.1186/s12935-015-0180-6

7. Anker P., Mulcahy H., Chen X.Q., Stroun M. Detection of circulating tumour DNA in the blood (plasma/serum) of cancer patients. Cancer Metastasis Rev. 1999;18(1):65- 73.

8. Bespalov V.G., Zhabin A.A., Stukov A.N., Belyaeva O.A., Murazov Y. G., Semenov A.L., Konkov S.A., Krylova I.M. Synergistic antitumor effect of dioxodate and cisplatin on the model of ovarian ascites tumor. Sibirskiy onkologicheskiy zhurnal = Siberian Journal of Oncology. 2013;1:42-46.

9. Bleiblo F., Michael P., Brabant D., Ramana C.V., Tai T., Saleh M., Parrillo J.E., Kumar A., Kumar A. The role of immunostimulatory nucleic acids in septic shock. Int. J. Clin. Exp. Med. 2012;5. ISSN:1940-5901/IJCEM1112008.

10. Blohin N.N., Perevodchikova N.I. Khimioterapiya opukholevykh zabolevaniy [Chemotherapy of neoplastic diseases]. Moscow, Meditsina, 1984.

11. Brenner D.E. Intraperitoneal chemotherapy: a review. J. Clin. Oncol. 1986;4(7):1135- 1147.

12. Decker P., Wolburg H., Rammensee H.G. Nucleosomes induce lymphocyte necrosis. Eur. J. Immunol. 2003;33(7):1978-1987. DOI 10.1002/eji.200323703

13. Dolgova E.V., Alyamkina E.A., Efremov Y.R., Nikolin V.P., Popova N.A., Tyrinova T.V., Kozel A.V., Minkevich A.M., Andrushkevich O.M., Zavyalov E.L., Romaschenko A.V., Bayborodin S.I., Taranov O.S., Omigov V.V., Shevela E.Y., Stupak V.V., Mishinov S.V., Rogachev V.A., Proskurina A.S., Mayorov V.I., Shurdov M.A., Ostanin A.A., Chernykh E.R., Bogachev S.S. Identification of cancer stem cells and a strategy for their elimination. Cancer Biol. Ther. 2014;15(10):1378-1394. DOI 10.4161/cbt.29854

14. Dolgova E.V., Efremov Y.R., Orishchenko K.E., Andrushkevich O.M., Alyamkina E.A., Proskurina A.S., Bayborodin S.I., Nikolin V.P., Popova N.A., Chernykh E.R., Ostanin A.A., Taranov O.S., Omigov V.V., Minkevich A.M., Rogachev V.A., Bogachev S.S., Shurdov M.A. Delivery and processing of exogenous double-stranded DNA in mouse CD34+ hematopoietic progenitor cells and their cell cycle changes upon combined treatment with cyclophosphamide and double-stranded DNA. Gene. 2013;528(2):74-83. DOI 10.1016/j.gene.2013.06.058

15. Dolgova E.V., Proskurina A.S., Nikolin V.P., Popova N.A., Alyamkina E.A., Orishchenko K.E., Rogachev V.A., Efremov Y.R., Dubatolova T.D., Prokopenko A.V., Chernykh E.R., Ostanin A.A., Taranov O.S., Omigov V.V., Zagrebelniy S.N., Bogachev S.S., Shurdov M.A. “Delayed death” phenomenon: A synergistic action of cyclophosphamide and exogenous DNA. Gene. 2012;495(2):134-145. DOI 10.1016/j.gene.2011.12.032

16. Dolgova E.V., Rogachev V.A., Nikolin V.P., Popova N.A., Likhacheva A.S., Alyamkina E.A., Sebeleva T.E., Chernykh E.R., Gelfgat E. L., Bogachev S.S., Shurdov M.A. Leukostimulatory effect of exogenous DNA fragments protected by protamine in mica in the case of myelosuppression caused by cyclophosphamide. Voprosy onkologii = Problems in Oncology. 2009;55(6):761-764.

17. Garcia-Olmo D., Garcia-Olmo D.C., Ontanon J., Martinez E. Horizontal transfer of DNA and the “genometastasis hypothesis”. Blood. 2000;95(2):724-725.

18. Garlatti V., Chouquet A., Lunardi T., Vives R., Paidassi H., Lortat-Jacob H., Thielens N.M., Arlaud G.J., Gaboriaud C. Cutting edge: C1q binds deoxyribose and heparin sulfate through neighboring sites of its recognition domain. J. Immunol. 2010;185(2):808-812. DOI 10.4049/jimmunol.1000184.

19. Gavrilov O.K. Problemy i gipotezy v uchenii o svertyvanii krovi [Problems and Hypotheses in the Study of Blood Coagulation]. Moscow, Meditsina, 1981.

20. Gupta P.B., Fillmore C.M., Jiang G., Shapira S.D., Tao K., Kuperwasser C., Lander E.S. Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells. Cell. 2011;146(4):633- 644. DOI 10.1016/j.cell.2011.07.026

21. Jahr S., Hentze H., Englisch S., Hardt D., Fackelmayer F.O., Hesch R.D., Knippers R. DNA fragments in the blood plasma of cancer patients quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res. 2001;61(4):1659-1665.

22. Jiang H., Cooper B., Robey F.A., Gewurz H. DNA binds and activates complement via residues 14-26 of the human C1q A chain. J. Biol. Chem. 1992;267(35):25597-25601.

23. Kaczorowski D.J., Scott M.J., Pibris J.P., Afrazi A., Nakao A., Edmonds R.D., Kim S., Kwak J.H., Liu Y., Fan J., Billiar T.R. Mammalian DNA is an endogenous danger signal that stimulates local synthesis and release of complement factor B. Mol. Med. 2012;18(1): 851-860. DOI 10.2119/molmed.2012.00011

24. Laktionov P.P., Tamkovich S.N., Rykova E.Y., Bryzgunova O.E., Starikov A.V., Kuznetsova N.P., Sumarokov S.V., Kolomiets S.A., Sevostianova N.V., Vlassov V.V. Extracellular circulating nucleic acids in human plasma in health and disease. Nucleosides Nucleotides Nucl. Acids. 2004;23(6-7):879-883.

25. Light R.W. Pleural Disease. Baltimore, Lippincott Williams & Wilkins, 1980. (Russ. ed.: Layt R.U. Bolezni plevry. Moscow, Medicina, 1986:106-119).

26. Parsons D.F., Marko M., Braun S.J., Wansor K.J. Ascites tumor invasion of mouse peritoneum studied by high-voltage electron microscope stereoscopy. Cancer Res. 1982;42(11):4574-4583.

27. Potter Е.А., Dolgova Е.V., Minkevich А.М., Efremov Ya.R., Taranov О.S., Omigov V.V., Nikolin V.P., Popova N.A., Proskurina А.S., Vereschagin Е.I., Kozel А.V., Rogachev V.А., Petrov D.B., Ostanin А.А., Chernykh Е.R., Kolchanov N.А., Bogachev S.S. Therapeutic effects of cyclophosphamide, dsDNA preparations and their combinations against Krebs-2 ascites cancer cells and various cancer transplants. Vavilovskii Zhurnal Genetiki i Selektsii = Vavilov Journal of Genetics and Breeding. 2016;20(1):96-107. DOI 10.18699/VJ15.116

28. Stenina M.B. Controversial issues in the treatment of ovarian cancer. Trudnyy patsient: spetsvypusk “Onkologiya” = An inveterate patient: Oncology. 2006;4(11):9- 14.

29. Tissot B., Daniel R., Place C. Interaction of the C1 complex of the complement with sulfated polysaccharide and DNA probed by single molecule fluorescence microscopy. Eur. J. Biochem. 2003;270(23): 4714-4720.

30. Tuaeva N.O., Sofronov V.V., Amikeeva V.A., Abramova Z.I., Winter V.G., Mustafina D.M., Tutochkina K.V. Interconnection of extracellular DNA concentration in blood plasma and amount of antibodies to native DNA in newborns with pneumopathy. Kazanskiy meditsinskiy zhurnal = Kazan Medical Journal. 2006;87(4):254-257.

31. Volkova O.V., Eleckii Yu.K. Osnovy gistologii i gistologicheskoy tekhniki [The Fundamentals of Histology and Histological Technique]. Moscow, Meditsina, 1971.